Rani Therapeutics Holdings (RANI) Stock Highlights

1.4 | +7.69%

2024-12-21 06:36:22

Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.

Statistics

Range Today

1.3 1.41

Volume Today 461.2K

Range 1 Year

1.3 8.75

Volume 1 Year 135.48M

Range 3 Year

1.3 27.13

Volume 3 Year 163.06M

Range 10 Year

1.3 36.27

Volume 10 Year 183.8M

Highlights

Market Capitalization 145.25M (small)

Floating Shares 20.43M

Current Price 1.4

Price To Earnings -2.22

Price To Book 22.52

Earnings Per Share -1.13

Payout Ratio 0%

Performance

Latest +7.69%

1 Month -32.37%

3 Months -40.43%

6 Months -64.1%

1 Year -55.13%

3 Years -92.13%

5 Years -87.61%

10 Years -87.61%

Benchmarks

Market Capitalization

234 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

242 / 368

Free Cashflow

165 / 352

Performance 5 years

254 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.